Literature DB >> 12109672

Liver transplantation for fulminant hepatic failure.

David H Van Thiel1, John Brems, Abdul Nadir, Ramazan Idilman, Alessandra Colantoni, David Holt, Steven Edelstein.   

Abstract

The etiology and prognosis of individuals with various forms of fulminant hepatic failure are reviewed. Special techniques of clinical management and decision making as to when and to whom to transplant in cases of fulminant hepatic failure are reviewed.

Entities:  

Mesh：

Year:  2002        PMID： 12109672     DOI： 10.1007/bf02990105

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


  14 in total

1.  Living related liver transplantation for acute liver failure in children.

Authors:  S Emre; M E Schwartz; B Shneider; J Hojsak; L Kim-Schluger; T M Fishbein; S R Guy; P A Sheiner; N S LeLeiko; A Birnbaum; F J Suchy; C M Miller
Journal:  Liver Transpl Surg       Date:  1999-05

Review 2.  Split liver/auxiliary liver transplantation for fulminant hepatic failure.

Authors:  P Neuhaus; W O Bechstein
Journal:  Liver Transpl Surg       Date:  1997-09

3.  Transplantation of complete and split liver grafts for patients with fulminant hepatic failure.

Authors:  M Sterneck; L Fischer; P Buggisch; M Malago; X Rogiers; M Burdelski; H Greten; C E Broelsch
Journal:  Z Gastroenterol       Date:  1996-12       Impact factor: 2.000

Review 4.  Renal failure in acute liver failure.

Authors:  K Moore
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-09       Impact factor: 2.566

5.  The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival.

Authors:  C Trey
Journal:  Can Med Assoc J       Date:  1972-02-26       Impact factor: 8.262

6.  Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure.

Authors:  S Miwa; Y Hashikura; A Mita; T Kubota; H Chisuwa; Y Nakazawa; T Ikegami; M Terada; S Miyagawa; S Kawasaki
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

7.  When should a decision to proceed with transplantation actually be made in cases of fulminant or subfulminant hepatic failure: at admission to hospital or when a donor organ is made available?

Authors:  D H Van Thiel
Journal:  J Hepatol       Date:  1993-01       Impact factor: 25.083

Review 8.  Acute liver failure.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

Review 9.  Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure.

Authors:  S M Riordan; R Williams
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

10.  Living-related liver transplantation and neurological outcome in children with fulminant hepatic failure.

Authors:  H Hattori; Y Higuchi; M Tsuji; Y Inomata; S Uemoto; K Asonuma; H Egawa; T Kiuchi; K Furusho; Y Yamaoka; K Tanaka
Journal:  Transplantation       Date:  1998-03-15       Impact factor: 4.939
View more
  5 in total

1.  Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience.

Authors:  Cataldo Doria; Lucio Mandalá; Victor L Scott; Salvatore Gruttadauria; Ignazio R Marino
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 2.  [Acute liver failure].

Authors:  K Rifai; M J Bahr
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

3.  Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial.

Authors:  Gadi Lalazar; Tomer Adar; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

4.  Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure.

Authors:  Lu Chen; Bingyu Xiang; Xiaojun Wang; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2017-01-23       Impact factor: 6.832

5.  SKLB023 protects mice against acute liver injury by inhibiting proinflammatory cytokine production in both T cells and macrophages.

Authors:  Jia Yu; Lili Liu; Huiming Zhang; Yating Wu; Heying Pei; Liang Ma; Anwen Xiong; Caifeng Xie
Journal:  RSC Adv       Date:  2018-09-27       Impact factor: 3.361
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.